DYN
Dyne Therapeutics Inc
16.00$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +619.1% | -13.5% | -100.7% | – | – | – | – | – | – | – | |
| – | +110.3% | +24.8% | +13.2% | -100.0% | +1,029.2% | +158.3% | +55.4% | +54.7% | -0.6% | -215.4% | – | |
| – | +47.4% | +10.7% | +41.9% | -100.0% | +2,500.0% | +25,250.0% | +166.2% | -13.5% | +31.6% | +129.6% | 0.0% | |
| – | – | – | – | – | +6,031.8% | +422.8% | +174.8% | -6.4% | – | – | – | |
| – | -183.6% | – | -270.1% | – | +133.8% | +263.8% | +81.1% | -158.1% | – | -174.1% | – | |
| – | – | +18.5% | -31.3% | -99.9% | +1,129.1% | -29.5% | +211.6% | -15.2% | -76.2% | +225.9% | -19.2% | |
| – | -76.8% | +79.8% | +28.5% | -100.0% | +1,129.1% | +2,672.4% | +202.0% | – | -4.5% | -345.0% | -85.9% | |
| – | – | -4.3% | +0.0% | – | – | – | – | – | – | – | – | |
| – | -86.6% | – | – | – | +169.3% | – | – | – | – | – | – | |
| – | – | – | – | – | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | -105.1% | – | -147.4% | – | +60.9% | +1,804.5% | -58.5% | -76.3% | +45.3% | +1,390.9% | +9.9% | |
| – | – | – | -373.2% | – | -47.6% | +4,333.3% | -134.5% | – | – | – | +46.2% | |
| – | – | – | +3.1% | -101.2% | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.